Budesonide Inhaler Market is Anticipated to Increase at a Stable CAGR over the Forecast Period (2023 to 2029)
Budesonide Inhaler Market is expected to grow at a significant CAGR during the forecast period. Budesonide is a corticosteroid drug that is used for the prevention and treatment of various symptoms including coughing, wheezing, chest tightness, and shortness of breath caused due to asthma and chronic obstructive pulmonary disease (COPD). This medication directly acts on the lungs and reduces the swelling and irritation of the airways to treat asthma and COPD-like conditions.
The increasing demand for
efficient treatment for various respiratory diseases including asthma, COPD,
nasal congestion, and others is anticipated to propel the demand for budesonide
inhalers and drive its market growth during the forecast period. The growing
prevalence of asthma disease and other breathing problems due to the increasing
rate of air pollution across the globe is further expected to elevate the need
for budesonide inhalers, as preventive medicine for such health care
conditions. This factor will contribute significantly to the growth of the
global budesonide inhaler market during the forecast period. The growing number
of patients suffering from respiratory diseases and the requirement for
long-term treatment is creating new opportunities for the budesonide inhaler in
the market across the globe. Additionally, the rising number of launches in
generic versions of budesonide inhalers is further projected to witness
lucrative growth opportunities for the global budesonide inhaler market.
The global budesonide inhaler
market includes some of the key vendors including AstraZeneca, Cosmo
Pharmaceuticals, Teva Pharmaceuticals, among others. To maintain a strong
position in the market, these market players are adopting various strategies
that include product launches, partnerships and collaborations, technological
advancement, and mergers and acquisitions. For instance, in July 2020,
AstraZeneca announced the FDA approval of Breztri Aerosphere, a combinational
drug of budesonide/glycopyrrolate/formoterol used for the treatment of patients
with chronic obstructive pulmonary disease (COPD).
To Request a Sample of our Report on Budesonide
Inhaler Market: https://www.omrglobal.com/request-sample/budesonide-inhaler-market
Market Coverage
·
The market number available for – 2022-2030
·
Base year- 2022
·
Forecast period- 2023-2030
Segment Covered
·
Regions Covered- Globally
·
Competitive Landscape- AstraZeneca, Cosmo Pharmaceuticals,
Teva Pharmaceuticals, Pfizer, Mylan, Orion Corporation, Lupin Limited, among
others.
Budesonide Inhaler Market by Segment
By Product Type
·
Inhalants
·
Nebulizers
By Dosage
·
Aerosols
·
Dry Powder
·
Spray
·
Suspension
By Distribution Channel
·
Hospital Pharmacy
·
Online Pharmacy
·
Retail Pharmacy
A
full Report of Budesonide Inhaler Market is Available @ https://www.omrglobal.com/industry-reports/budesonide-inhaler-market
Budesonide Inhaler Market by Region
· United
States
· Canada
Europe
· UK
· Germany
· Spain
· France
· Italy
· Rest
of Europe
Asia-Pacific
· India
· China
· Japan
· South
Korea
· Rest
of APAC
Rest of the World
Reasons to buy from us –
1. We cover more than
15 major industries, further segmented into more than 90 sectors.
2. More than 120
countries are for analysis.
3. Over 100+ paid
data sources mined for investigation.
4. Our expert
research analysts answer all your questions before and after purchasing your
report.
For More Customized Data,
Request for Report Customization @ https://www.omrglobal.com/report-customization/budesonide-inhaler-market
About Orion Market Research
Orion Market
Research (OMR) is a market research and consulting company known for its crisp
and concise reports. The company is equipped with an experienced team of
analysts and consultants. OMR offers quality syndicated research reports,
customized research reports, consulting and other research-based services. The
company also offer Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services
through another subsidiary Encanto Technologies.
Media
Contact:
Company
Name: Orion Market Research
Contact
Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact
no: +91 7803040404
Comments
Post a Comment